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ABSTRACT
Objectives Patients who present in primary care with 
chronic functional somatic symptoms (FSS) have reduced 
quality of life and increased health care costs. Recognising 
these early is a challenge. The aim is to develop and 
internally validate a clinical prediction rule for repeated 
consultations with FSS.
Design and setting Records from the longitudinal 
population- based (‘Lifelines’) cohort study were linked to 
electronic health records from general practitioners (GPs).
Participants We included patients consulting a GP 
with FSS within 1 year after baseline assessment in the 
Lifelines cohort.
Outcome measures The outcome is repeated 
consultations with FSS, defined as ≥3 extra consultations 
for FSS within 1 year after the first consultation. 
Multivariable logistic regression, with bootstrapping for 
internal validation, was used to develop a risk prediction 
model from 14 literature- based predictors. Model 
discrimination, calibration and diagnostic accuracy were 
assessed.
Results 18 810 participants were identified by database 
linkage, of whom 2650 consulted a GP with FSS and 297 
(11%) had ≥3 extra consultations. In the final multivariable 
model, older age, female sex, lack of healthy activity, 
presence of generalised anxiety disorder and higher 
number of GP consultations in the last year predicted 
repeated consultations. Discrimination after internal 
validation was 0.64 with a calibration slope of 0.95. The 
positive predictive value of patients with high scores on 
the model was 0.37 (0.29–0.47).
Conclusions Several theoretically suggested predisposing 
and precipitating predictors, including neuroticism and 
stressful life events, surprisingly failed to contribute to our 
final model. Moreover, this model mostly included general 
predictors of increased risk of repeated consultations 
among patients with FSS. The model discrimination and 
positive predictive values were insufficient and preclude 
clinical implementation.
INTRODUCTION
Functional somatic symptoms (FSS), a synon-
ymous of medically unexplained physical 
symptoms, represent those that cannot be 
explained by a physical disease and account 
for about one- third of all presentations in 
primary care,1 2 clustering as cardiopulmo-
nary, musculoskeletal, gastrointestinal and 
general somatic symptoms.3 4 However, these 
clusters appear to correlate and considered 
to represent one condition with different 
manifestations.5 Most patients with FSS 
consult a general practitioner (GP) only 
once, but 10%–30% of cases will become 
chronic,6 leading to more diagnostic tests, 
more referrals, higher healthcare costs and 
more psychological distress compared with 
other patients.7–9 Recognising those patients 
at risk of developing chronic symptoms and 
consulted repeatedly the GP could there-
fore help to target interventions that reduce 
symptom severity,10 11 improve quality of life 
and reduce GP workloads. Ensuring that these 
patients are identified early is an important 
challenge facing GPs,12 and one for which a 
validated clinical prediction rule may help. 
Strengths and limitations of this study
 ► This study offers valuable insights into the predic-
tors that could help general practitioners (GPs) to 
identify repeated consultations with functional so-
matic symptoms.
 ► By linking routine healthcare data from primary care 
to a large population- based cohort, we could include 
relevant predictors based on epidemiological and 
theoretical factors from the literature and this ap-
proach may serve to enhance primary care research 
in the future.
 ► Each patient had a full follow- up of 1 year.
 ► Time from baseline assessment of the population- 
based cohort to first GP consultation varied, how-
ever, taking this variance into account did not affect 
the magnitude of the coefficients of the predictors in 
a substantial way, nor their selection.
 ► We did not externally validate the model, however 
the performance needs to be improved before such 
research can be considered.
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Several factors are known to increase the risk of chro-
nicity of FSS, including predisposing (eg, neuroticism), 
precipitating (eg, physical and psychosocial stressors) 
and perpetuating (eg, lack of healthy physical activity) 
factors.13–15 Despite being described in the literature,6 
these factors have yet to be combined to predict repeated 
consultations with FSS in a clinical prediction rule for use 
in primary care.
In this study, we aimed to develop and internally vali-
date a clinical prediction rule for repeated consultations 
among patients who consult GPs with FSS.
METHOD
Data sources
We linked patient records from the Lifelines Cohort 
Study (‘Lifelines’)16 with those from the Nivel Primary 
Care Database (NPCD).17 Dutch law conditionally allows 
the use of such electronic health records for research 
purposes. Statistics Netherlands (CBS) then used tempo-
rary record identification numbers to link records at an 
individual level for analysis.
Lifelines is a multidisciplinary prospective population- 
based cohort study using a three- generation design to 
examine the health and health- related behaviours of 
167 729 people living in the north of the Netherlands.16 
It employs a broad range of investigative procedures to 
assess key factors that contribute to health and disease in 
the general population, focusing on multimorbidity and 
complex genetics. Lifelines was conducted in accordance 
with the Declaration of Helsinki. All participants signed 
an informed consent form.
The NPCD contains routinely recorded clinical data 
from GP consultations with patients, and is considered 
representative of the Dutch population.17 The Dutch 
healthcare system is such that all non- institutionalised 
members of the population are registered with a general 
practice, which in turn, serves as a gatekeeping system 
through which patients must pass to access specialist care 
via GP referral.18 In total, 528 general practices partici-
pated in 2019, and this study was approved according to 
the Nivel Governance Code (number NZR0317.033).
For the current study, we included the baseline data of 
152 728 adults enrolled in Lifelines between November 
2006 and June 2013, and we linked these with the elec-
tronic health records of GP consultations for patients 
aged ≥18 years who consulted one of the 65 general prac-
tices in the north of the Netherlands that participated in 
the NPCD.
Patient population
We planned to include adults with FSS considered at risk 
of consulting the GP repeatedly, which we defined as 
those having a GP consultation for FSS in the year after 
their baseline assessment for Lifelines. The presence of 
FSS was assessed based on the International Classifica-
tion of Primary Care (ICPC) codes that related to the 
symptoms that Robbins et al described (see online supple-
mental table 1).19
Outcomes
The primary outcome was repeated consultations with 
FSS, defined as ≥3 extra GP consultations for one of the 
defined FSS (see online supplemental table 1) during 
a year of follow- up after first consulting a GP with that 
symptom.19 20 Complete follow- up data were recorded for 
all GP consultations in electronic health records, and we 
permitted the FSS to vary between consultations.
Candidate predictors
We selected 14 predictors based on literature review and 
expert opinion: age, sex, neuroticism, chronic stress, 
stressful life events, self- rated health, healthy activity, 
body mass index (BMI), living alone, higher education, 
major depressive disorder (MDD), generalised anxiety 
disorder (GAD), and psychiatric or GP consultations in 
the 12 months before first consulting with FSS.6 21 The 
data for these predictors were derived from the baseline 
of Lifelines, except for the psychiatric and GP consulta-
tions, which were derived from the NPCD.
Neuroticism was evaluated using an abridged version 
of the Neuroticism Extraversion Openness- Personality 
Inventory- Revised that included only anger- hostility, self- 
consciousness, impulsivity and vulnerability, and excluded 
depression and anxiety (score range, 4–32).22 Chronic 
stress was measured with the Long- term Difficulties 
Inventory (score range, 0–24).23 The List of Threatening 
Events was used to assess the occurrence of 12 stressful 
life events (score range, 0–12).23 24 Self- rated health was 
evaluated with the RAND-36 question25 ‘how would you 
rate your health from 1 (excellent) to 5 (poor).’ The 
Short Questionnaire to Assess Health- Enhancing Physical 
Activity was used to determine healthy activity behaviour, 
with a cut- off of 30 min at least 5 days a week indicating 
healthy activity.26 Body weight and height were used to 
calculate BMI (weight (kg)/height (m2)). Higher educa-
tion was defined as at least secondary vocational educa-
tion or work- based training. MDD and GAD were assessed 
by the Mini- International Neuropsychiatric Interview, 
compatible with International Classification of Disease, 
Tenth Edition, and the Diagnostic and Statistical Manual 
of Mental Disorders, Fourth Edition.27 Psychiatric consul-
tation was defined as patients with a consultation code 
in the P chapter of the ICPC and GP consultation was 
defined as the number of total GP consultations in the 12 
months before baseline of Lifelines.
Sample size
We estimated that we required 11 455 participants based 
on an assumption that 10% of the NPCD cohort would 
participate in Lifelines and that 75% of these data could 
be linked (ie, 10%×75%×152 728). Given that the prev-
alence of repeated consultations with FSS has been 
reported to be 2.5%, we estimated that 286 of these could 
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be included20 to achieve an effective sample size of at least 
20 outcome events per predictor.28
Missing data
Eleven predictors from Lifelines had missing data, so we 
evaluated the underlying causes and patterns to assess 
the conditions for multiple imputation.29 We checked 
predictors of missingness and we assumed missing at 
random (MAR) when patients with missing values were 
different from patients without missing values with 
respect to observed variables. When data are MAR, we 
replaced all missing values by multiple imputation by 
chained equations, incorporating all variables used in 
the analyses, including the outcome variable, and all vari-
ables that predicted missingness of a certain variable or 
value. We imputed questionnaire sum scores rather than 
item scores. Finally, we constructed 20 imputed data sets 
combined across all data sets, pooled β coefficients and 
calculated ORs using Rubin’s rule.30
Statistical analysis
Repeated consultations with FSS over a 1- year follow- up 
period was set as the binary outcome variable and asso-
ciated with potential predictors as independent variables 
in logistic regression analyses. We performed univariable 
analyses to calculate unadjusted ORs.
To develop the clinical prediction rule, we initially 
included all potential predictors in a multivariable logistic 
regression model, irrespective of their univariable asso-
ciation and refrained from univariable preselection of 
candidate predictors to prevent model instability.31 Using 
backward stepwise selection, we excluded predictors from 
the model that were not statistically significant according 
to Akaike’s information criterion (ie, p>0.157) in >50% 
of all imputed data sets.32 Time in days between baseline 
assessment of predictors and first consultation differed 
between participants, so we also evaluated its influence 
in a separate analysis. We assessed rule performance 
by its discriminatory power with the C statistic and the 
calibration slope. We internally validated the model to 
correct for overoptimism by bootstrapping 250 samples, 
calculating a shrinkage factor, multiplying the original β 
coefficients by this factor, and re- estimating the intercepts 
using the shrunken β coefficients. The β coefficients were 
translated into a risk score of whole numbers for ease of 
use by GPs when evaluating the risk of repeated consulta-
tions in clinical practice. To that end, each β coefficient 
was divided by the coefficient closest to zero and then 
rounded to the nearest integer. The total score for each 
patient was calculated as the sum of all points for each 
predictor. We calculated the sensitivity, specificity and 
positive predictive value of the rule at several thresholds 
to distinguish high and low risk. Thresholds were chosen 
arbitrarily based on the sample sizes being adequate in 
each category and the clinical risk being distinguishable.
All statistical analyses were performed with Stata V.SE15 
(StataCorp, College Station, Texas, USA) and R (for boot-
strapping). The Transparent Reporting of a multivariable 
prediction model for Individual Prediction of Diagnosis 
was used to conduct this study and report its results.33
Patient and public involvement
Lifelines has a participant advisory board of eight active 
members with different backgrounds since 2016. The 
concept of this study was discussed during a meeting 
with this board. All Lifelines participants will receive the 
results of the study via a newsletter.
RESULTS
Study participants
Of the 152 728 Lifelines participants with a baseline assess-
ment, we linked 18 810 (12%) with NPCD data (figure 1). 
Among these, we included 2650 participants (14% of 
those linked) attending GP consultations for FSS (ie, the 
at- risk group), of whom 297 (11%) had ≥3 further consul-
tations for FSS (ie, the outcome criterion). The details 
of the included and excluded patients are summarised 
Lifelines 
(n = 152 728)
Linked with NPCD 
(n = 18 810)
GP consultation within 1 year 
(n = 10 068)
Consultation concerning FSS
 within 1 year
 (n = 2 650)
Patients with  3 extra consultations 
concerning FSS  
(n = 297)
 
Figure 1 Patient selection flowchart. ‘Extra consultations’ 
(≥3) refers to additional presentations for FSS during a 1- year 
follow- up period after an initial GP consultation for FSS. GP, 
general practitioner; FSS, functional somatic symptoms.
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in table 1, showing that the groups were broadly compa-
rable. Notably, 24% of participants had a missing value 
and 3% had missing values for >4 predictors. The partic-
ipants with missing values were slightly older and less 
active, and they less often had completed higher educa-
tion (see online supplemental table 2).
Clinical prediction rule
Univariable associations of the potential predictors for 
repeated consultations with FSS are listed in table 2. 
In the final multivariable model, the following five 
predictors were selected based on increasing the risk of 
repeated consultations: higher age, female sex, lack of 
healthy activity, presence of GAD and having had more 
GP consultations in the year before first consulting with 
FSS (table 3). Adjustment for time from baseline to first 
consultation did not affect the magnitude of the coef-
ficients of the predictors in a substantial way, nor their 
selection. The shrinkage factor of 0.95 showed limited 
model overfitting and was applied to adjust predictor 
coefficients in the final model. Likewise, the C statistic 
(area under the curve) of 0.65 (95% CI, 0.62 to 0.69) 
was corrected to 0.64 (95% CI, 0.61 to 0.68). Agreement 
between the observed and predicted proportion of events 
showed adequate calibration (see online supplemental 
figure 1).
The final model could calculate the absolute predicted 
individual risk of repeated consultations with FSS (see 
online supplemental figure 2). For a risk score ≥100, the 
positive predictive value of repeated consultations was 
0.37 (95% CI, 0.29 to 0.47) (tables 4 and 5). However, 
when increasing the cut- off from 25 to 100, the sensitivity 
decreased from 0.87 (95% CI, 0.83 to 0.91) to 0.13 (95% 
CI, 0.10 to 0.17) and the specificity increased from 0.23 
(95% CI, 0.22 to 0.25) to 0.97 (95% CI, 0.97 to 0.98).
DISCUSSION
Summary
We developed and internally validated a clinical predic-
tion rule to identify patients at high risk of repeated 
consultations with FSS. This was based on five factors 
that are readily available in primary care: age, sex, activity 
levels, GAD diagnosis and number of consultations. 
However, despite being well calibrated, the prediction 
rule showed poor discrimination. Nevertheless, if patients 
scored ≥100, the risk of repeated consultations with FSS 
increased to 37% from the baseline value of 11%.
Strengths and limitations
The study benefited from the use of a rich data set estab-
lished by linking routine electronic health record data 
from primary care to a large population- based cohort. 
We effectively linked 18 810 patients (12%) from Life-
lines who had at least one GP consultation, and we could 
include predictors based on epidemiological and theo-
retical factors from the literature, such as neuroticism 
and stressful life events.21 The data linkage approach that 
Table 1 Characteristics of included and excluded patients
Included patients* (n=2650) Excluded patients† (n=7418)
  N (%) Score n Score
Age, mean years (SD) 2636 (99) 45 (14) 7387 45 (14)
Female, n (%) 2650 (100) 1802 (68) 7418 4577 (62)
Neuroticism, median (IQR) 2248 (85) 10.1 (9.1–11.3) 6419 9.9 (8.9–11)
Chronic stress, median (IQR) 2465 (93) 2 (1–4) 7005 2 (1–4)
Stressful life events, median (IQR) 2464 (93) 1 (0–2) 7008 1 (0–2)
Self- rated health, median (IQR) 2548 (96) 3 (2–3) 7228 3 (2–3)
Healthy activity‡, n (%) 2274 (86) 1259 (55) 6505 3589 (55)
Body mass index (kg/m2), median (IQR) 2648 (100) 26 (23–28) 7417 25 (23–28)
Living alone, n (%) 2522 (95) 335 (13.3) 7167 904 (12.6)
Higher education§, n (%) 2572 (97) 1707 (66) 7215 5067 (70)
MDD, n (%) 2555 (96) 86 (3) 7248 176 (2.4)
GAD, n (%) 2555 (96) 165 (6) 7248 351 (4.8)
Psychiatric consultations last year¶**, n (%) 2650 (100) 292 (11) 7418 783 (11)
GP consultations last year**, median (IQR) 2650 (100) 2 (0–5) 7418 1 (0–3)
*Included: GP consultations and ≥1 FSS within 1 year after baseline Lifelines assessment.
†Excluded: GP consultations without FSS within 1 year after baseline of Lifelines.
‡Healthy activity, defined as 30 min at least 5 days a week.
§Higher education, defined as at least secondary vocational education or work- based training.
¶Patients with a consultation code in the P chapter of the International Classification of Primary Care.
**Predictors from NPCD. Other predictors are from Lifelines.
GAD, generalised anxiety disorder; GP, general practitioner; MDD, major depressive disorder; NPCD, Nivel Primary Care Database.
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we adopted may serve to enhance primary care research 
in the future. Each patient also had follow- up data for 
a full year, and although the time from baseline assess-
ment in Lifelines to first GP consultation varied because 
of the dynamic nature of the NPCD cohort, this did not 
affect the results. Another strength is that we included 
21 events per variable, resulting in minimal overfitting 
with a shrinkage factor of 0.95. An advantage of using 
dichotomous over continuous outcomes is that clinical 
interpretation is more straightforward. Although it is 
problematic that we did not externally validate the model, 
we contend that the model’s performance will need to be 
improved before such research can be considered.
Our model predicts the risk of having ≥3 extra consul-
tations for FSS. A developing underlying somatic disease 
could be suggested to ultimately explain some of these 
symptoms, however, a meta- analysis suggested that this 
risk is very low, reporting only 0.5% new diagnoses in 
follow- up studies of FSS.34 FSS should not be confused 
with predicting a somatic symptom disorder or functional 
somatic syndrome, not least because we could not deter-
mine these diagnoses with the available data. In addition, 
about 80% of patients with functional somatic syndrome 
will be missed using GP medical files.35 A disadvantage of 
our outcome measure is that patients with FSS may also 
have consulted other healthcare professionals (eg, phys-
iotherapist), so these cases may have been missed. There-
fore, the interpretation of our model is only applicable 
for GP consultations. We chose to use a follow- up of 1 
year as this is often used in previous studies,20 36 however 
persistent frequent attenders in primary care have more 
often FSS.37 Therefore, a clinical prediction rule for 
Table 2 Univariable analysis of predictors for repeated 
consultations with FSS
Variable
Repeated consultations* OR 
(95% CI)
Age 1.01 (1.00 to 1.02)
Sex (male) 0.69 (0.52 to 0.91)
Neuroticism 1.08 (0.99 to 1.17)
Chronic stress 1.04 (0.99 to 1.09)
Stressful life events 1.08 (0.99 to 1.18)
Self- rated health 1.41 (1.20 to 1.66)
Healthy activity† 0.70 (0.53 to 0.91)
Body mass index (kg/m2) 1.04 (1.01 to 1.07)
Living alone 0.91 (0.62 to 1.32)
Higher education‡ 0.75 (0.58 to 0.96)
MDD 1.53 (0.85 to 2.73)
GAD 2.15 (1.45 to 3.19)
Psychiatric consultations 
last year§¶
1.17 (1.04 to 1.33)
GP consultations last year¶ 1.12 (1.09 to 1.15)
*Outcome, ≥3 extra FSS consultations during a 1- year follow- up 
period (n=297).
†Healthy activity, defined as 30 min at least 5 days a week.
‡Higher education, defined as at least secondary vocational 
education or work- based training.
§Number of consultations concerning International Classification 
of Primary Care codes in the P chapter.
¶Predictors are from NPCD and are continuous. Other predictors 
are from the Lifelines database.
FSS, functional somatic symptoms; GAD, generalised anxiety 
disorder; GP, general practitioner; MDD, major depressive disorder; 
NPCD, Nivel Primary Care Database.
Table 3 Final multivariable analysis for repeated consultations with FSS
Predictors OR (95% CI) P value Coefficient Adjusted coefficient Risk score
Constant 0.05 (0.03 to 0.08) 0.000 −2.95 −3.80
Age 1.02 (1.01 to 1.03) 0.000 0.02 0.02 1
Sex (male) 0.75 (0.56 to 0.99) 0.042 −0.30 −0.29 −15
Healthy activity* 0.60 (0.45 to 0.80) 0.001 −0.51 −0.48 −24
GAD 1.79 (1.17 to 2.74) 0.008 0.58 0.56 28
GP consultations last year 1.10 (1.07 to 1.14) 0.000 0.10 0.10 5
Shrinkage factor 0.95; predictors selected if p<0.157.
*Healthy activity, defined as 30 min at least 5 days a week.
FSS, functional somatic symptoms; GAD, generalised anxiety disorder; GP, general practitioner.
Table 4 Risk of repeated consultations with FSS by 







<25 585 38 0.07 0.06
25–49 1009 82 0.08 0.08
50–99 952 138 0.15 0.14
≥100 104 39 0.38 0.37
The risk score was calculated by multiplying each risk score by 
the predictor value, with the total score ranging from −21 to 301 
for all included patients (for example, −21 represents the following 
patient: 18 years (18), man (−15), healthy activity (−24), no GAD 
(0), no GP consultation last year (0) (=18–15–24+0+0=−21); 
and 301: 63 years (63), woman (0), lack of healthy activity (0), 
presence of GAD (28), 42 GP consultations last year (210) 
(=63+0+0+28+210=301)).
FSS, functional somatic symptoms; GAD, generalised anxiety 
disorder; GP, general practitioner.
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repeated consultations with FSS during a longer follow- up 
might perform better. To avoid confusion and misunder-
standing, we used the more neutral outcome of repeated 
consultations because our data did not allow for the iden-
tification of frequent attenders as defined in present day 
literature. The latter requires a comprehensive descrip-
tion of the contacts counted, for example, how many 
were out- of- hours contacts, and how many were adminis-
trative or preventive consultations.36 As we did not want to 
include too many predictors per variable to prevent over-
fitting, we a priori choose which predictors were relevant 
and feasible to use in a primary care setting. By this arbi-
trary selection, we may have missed relevant predictors 
(e.g. panic disorder and number of physical symptoms) 
that could have improved the performance of our predic-
tion rule.6 38 Our approach to identify the at- risk popu-
lation first may explain the contrast with existing data. 
For example, we showed that 11% of patients presenting 
with FSS ultimately had ≥4 consultations for these symp-
toms, whereas previous research has shown a rate of 2.5% 
among all patients with GP consultations.20
Comparison with other studies
We are aware of no other clinical prediction rules for 
repeated GP consultations with FSS. It should be empha-
sised that such a model cannot be considered synony-
mous with explaining the cause.39 However, we found 
three studies that developed models for persistent FSS 
by combining predictors using a backward or forward 
selection procedure. We limit our discussion to the three 
studies that developed a clinical prediction rule.
The first study used information from GP letters 
to medical specialists for patients who were referred 
with FSS.40 In their clinical prediction rule, female sex, 
referral symptom group, lack of somatic comorbidity, lack 
of abnormal physical findings, history of psychiatric diag-
nosis or treatment, and referral letter written in illness 
terminology were all shown to be predictors for FSS. This 
model had a higher area under the curve (0.82) than 
ours (0.64) and was developed for patients consulting 
internists. However, the GP referral letters included rele-
vant predictors that helped to identify FSS, and although 
the population was more selected than ours, the results 
show that data collected in primary care can be suitable 
predictors.
The second study showed that the use of routine health-
care could include relevant predictors and developed a 
clinical prediction rule that potentially could be used to 
identify patients at risk for persistent FSS from routine 
primary care medical records.41 The model had an area 
under the curve of 0.70 and the most important discrimi-
native variable for persistent FSS was number of episodes. 
Just like our model they also included the predictors age, 
sex and number of contacts.
The third study developed a model for symptom severity 
and for both physical and mental functioning during a 
2- year follow- up period among patients with persistent 
FSS.21 They predicted severe courses by physical comor-
bidity, higher baseline severity and longer physical 
symptom duration, anxiety, catastrophising cognitions, 
embarrassment and neuroticism, as well as fear avoid-
ance, avoidance or resting behaviour. By contrast, they 
predicted favourable courses based on limited alcohol use, 
higher education, higher baseline physical and mental 
functioning, symptom focusing, damage cognitions and 
extraversion. Although we also identified anxiety as a 
predictor, we did not find the same for neuroticism or 
higher education. Also contrasting with our data, as well 
as that of others,42 43 they did not show that female sex was 
a predictor. Unfortunately, we could not include predic-
tors of illness behaviour because these were not evaluated 
in Lifelines. Indeed, the Symptoms Checklist 90 question-
naire had more than 50% missing values during baseline 
evaluation in Lifelines, so we excluded these data.16 The 
differences in identified predictors may be explained by 
different study populations, predictor selection criteria or 
outcomes.
Implications for research and practice
To our surprise, several theoretically suggested predis-
posing and precipitating predictors, including neuroti-
cism and stressful life events, failed to contribute to the 
final prediction model. Instead, this model included 
mostly general predictors that provide little additional 
information to help GPs recognise patients at risk of 
consulting repeatedly with FSS, and it not only has poor 
discrimination and positive predictive value but also lacks 
external validation. Therefore, at present, we cannot 
recommend the score for clinical use. Nevertheless, our 
findings indicate that GPs might expect chronicity when 
older women with low activity levels and anxiety symp-
toms present with FSS. These require extra vigilance 
and may benefit from early intervention with self- help 
advice.11 Some predictors identified in earlier studies, 
such as female sex and anxiety, could be potential factors 
in future clinical prediction rules designed to help GPs 
recognise patients at risk of consulting the GP repeatedly.
Table 5 Diagnostic accuracy of the risk score for repeated consultations with FSS
Cut- off score n Sensitivity (95% CI) Specificity (95% CI) PPV (95% CI) NPV (95% CI)
≥25 2065 0.87 (0.83 to 0.91) 0.23 (0.22 to 0.25) 0.13 (0.11 to 0.14) 0.93 (0.91 to 0.95)
≥50 1057 0.59 (0.54 to 0.65) 0.63 (0.61 to 0.64) 0.17 (0.15 to 0.19) 0.92 (0.91 to 0.94)
≥100 104 0.13 (0.10 to 0.17) 0.97 (0.97 to 0.98) 0.37 (0.29 to 0.47) 0.91 (0.90 to 0.92)
FSS, functional somatic symptoms; NPV, negative predictive value; PPV, positive predictive value.
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